Gvans Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.70 M
About Gvans Biotech
Gvans Biotech Private Limited (GBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 January 2021 (Four years and one month 2 days old ). Its registered office is in Yamuna Nagar, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.70 M.
Rohit and Tinku serve as directors at the Company.
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909HR2021PTC092405
- Company No.
092405
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2021
- Date of AGM
31 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Gvans Biotech Private Limited offer?
Gvans Biotech Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Sexual Wellness Products, Fertility Enhancer, Anti Allergic Drug, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Gvans Biotech?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rohit ![]() | Managing Director | 22-Jan-2021 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tinku ![]() | Director | 22-Jan-2021 | Current |
Financial Performance of Gvans Biotech.
Enhance accessibility to Gvans Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Gvans Biotech?
Unlock access to Gvans Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹1.70 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.17 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Apr 2023 | Hdfc Bank Limited | ₹1.70 M | Open |
How Many Employees Work at Gvans Biotech?
Gvans Biotech has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Gvans Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gvans Biotech's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.